Cargando…

A New Tumor Burden Score and Albumin–Bilirubin Grade-Based Prognostic Model for Hepatocellular Carcinoma

SIMPLE SUMMARY: The survival of patients with hepatocellular carcinoma (HCC) is highly variables, due to heterogeneous tumor burden and liver dysfunction. Tumor burden score (TBS) is a continuous variable to measure the extent of tumor involvement, and the albumin–bilirubin (ALBI) grade is an object...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ho, Shu-Yein, Liu, Po-Hong, Hsu, Chia-Yang, Huang, Yi-Hsiang, Liao, Jia-I, Su, Chien-Wei, Hou, Ming-Chih, Huo, Teh-Ia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833827/ https://www.ncbi.nlm.nih.gov/pubmed/35158917 http://dx.doi.org/10.3390/cancers14030649

Ejemplares similares

Prognostic Prediction for Patients with Hepatocellular Carcinoma and Ascites: Role of Albumin-Bilirubin (ALBI) Grade and Easy (EZ)-ALBI Grade
por: Liao, Jia-I, et al.
Publicado: (2023)

Survival of Patients with Hepatocellular Carcinoma in Renal Insufficiency: Prognostic Role of Albumin-Bilirubin Grade
por: Ho, Shu-Yein, et al.
Publicado: (2020)

Radiofrequency Ablation versus Transarterial Chemoembolization for Hepatocellular Carcinoma within Milan Criteria: Prognostic Role of Tumor Burden Score
por: Ho, Shu-Yein, et al.
Publicado: (2022)

Surgical resection versus transarterial chemoembolization for patients with hepatocellular carcinoma beyond Milan criteria: prognostic role of tumor burden score
por: Ho, Shu-Yein, et al.
Publicado: (2023)

Comparison of Four Albumin-Based Liver Reserve Models (ALBI/EZ-ALBI/PALBI/PAL) against MELD for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
por: Ho, Shu-Yein, et al.
Publicado: (2023)

Impact of tumor burden on prognostic prediction for patients with terminal stage hepatocellular carcinoma: A nomogram study
por: Hsu, Chia-Yang, et al.
Publicado: (2017)

Evolution of etiology, presentation, management and prognostic tool in hepatocellular carcinoma
por: Ho, Shu-Yein, et al.
Publicado: (2020)

Author Correction: Evolution of etiology, presentation, management and prognostic tool in hepatocellular carcinoma
por: Ho, Shu-Yein, et al.
Publicado: (2020)

Prognostic Performance of Ten Liver Function Models in Patients with Hepatocellular Carcinoma Undergoing Radiofrequency Ablation
por: Ho, Shu-Yein, et al.
Publicado: (2018)

Current noninvasive liver reserve models do not predict histological fibrosis severity in hepatocellular carcinoma
por: Ho, Shu-Yein, et al.
Publicado: (2018)

Comparison of twelve liver functional reserve models for outcome prediction in patients with hepatocellular carcinoma undergoing surgical resection
por: Ho, Shu-Yein, et al.
Publicado: (2018)

Albumin-bilirubin score: an additional tool for the management of patients with hepatocellular carcinoma
por: Serenari, Matteo, et al.
Publicado: (2020)

Modified Albumin-Bilirubin Grade and Alpha-Fetoprotein Score (mALF Score) for Predicting the Prognosis of Hepatocellular Carcinoma after Hepatectomy
por: Kaibori, Masaki, et al.
Publicado: (2022)

A commentary on ‘development and validation of safety and efficacy-associated risk calculator for hepatocellular carcinoma in the elderly after resection (searcher): a multi-institutional observational study’ (Int J Surg 2022;106:106842)
por: Huo, Teh-Ia, et al.
Publicado: (2023)

A New Treatment-integrated Prognostic Nomogram of the Barcelona Clinic Liver Cancer System for Hepatocellular Carcinoma
por: Hsu, Chia-Yang, et al.
Publicado: (2017)

Prognostic impact of diabetes mellitus on hepatocellular carcinoma: Special emphasis from the BCLC perspective
por: Su, Yu-Wen, et al.
Publicado: (2017)

A commentary on ‘Nomograms for predicting the recurrence probability and recurrence-free survival in patients with hepatocellular carcinoma after conversion hepatectomy based on hepatic arterial infusion chemotherapy: a multicenter, retrospective study’ (Int J Surg 2023; 109:1299–310)
por: Huo, Teh-Ia, et al.
Publicado: (2023)

Albumin-bilirubin grade as a prognostic factor of hepatocellular carcinoma after treatment with orthotopic liver transplantation
por: Liao, Jianhua, et al.
Publicado: (2019)

Prognostic role of noninvasive liver reserve markers in patients with hepatocellular carcinoma undergoing transarterial chemoembolization
por: Ho, Shu-Yein, et al.
Publicado: (2017)

Prognostic value of the albumin-bilirubin grade in patients with hepatocellular carcinoma and other liver diseases
por: Feng, Dayun, et al.
Publicado: (2020)

Neutrophil to lymphocyte ratio and albumin bilirubin grade in hepatocellular carcinoma: A systematic review
por: Bannaga, Ayman, et al.
Publicado: (2020)

Efficacy and safety of cabozantinib for patients with advanced hepatocellular carcinoma based on albumin-bilirubin grade
por: Kelley, Robin Kate, et al.
Publicado: (2021)

On-Treatment Albumin-Bilirubin Grade: Predictor of Response and Outcome of Sorafenib-Regorafenib Sequential Therapy in Patients with Unresectable Hepatocellular Carcinoma
por: Wang, Hung-Wei, et al.
Publicado: (2021)

Comparing various scoring system for predicting overall survival according to treatment modalities in hepatocellular carcinoma focused on Platelet-albumin-bilirubin (PALBI) and albumin-bilirubin (ALBI) grade: A nationwide cohort study
por: Lee, Soon Kyu, et al.
Publicado: (2019)

Assessment in the Survival Outcome After Transarterial Chemoembolization Combined with Cryoablation for Hepatocellular Carcinoma (Diameter > 4cm) Based on the Albumin-Bilirubin Grade and Platelet-Albumin-Bilirubin ‎grade: ‎ A Preliminary Study
por: Huang, Zhimei, et al.
Publicado: (2020)

Modified Albumin–Bilirubin Model for Stratifying Survival in Patients with Hepatocellular Carcinoma Receiving Anticancer Therapy
por: Hsu, Wei-Fan, et al.
Publicado: (2022)

Uncompromised Treatment Efficacy in Elderly Patients With Hepatocellular Carcinoma: A Propensity Score Analysis
por: Liu, Po-Hong, et al.
Publicado: (2014)

Comparison between Child-Pugh Score and albumin-bilirubin grade in patients treated with the combination therapy of transarterial chemoembolization and sorafenib for hepatocellular carcinoma
por: Wang, Zhexuan, et al.
Publicado: (2020)

Using nomogram of the Barcelona Clinic Liver Cancer system for treatment selection in patients with stage C hepatocellular carcinoma
por: Hsu, Chia-Yang, et al.
Publicado: (2018)

Prognostic Performance of Albumin–Bilirubin Grade With Artificial Intelligence for Hepatocellular Carcinoma Treated With Transarterial Chemoembolization Combined With Sorafenib
por: Zhong, Bin-Yan, et al.
Publicado: (2020)

Modified Child-Pugh grade vs albumin-bilirubin grade for predicting prognosis of hepatocellular carcinoma patients after hepatectomy
por: Huang, Feng, et al.
Publicado: (2020)

Albumin-bilirubin and platelet-albumin-bilirubin grades for hepatitis B-associated hepatocellular carcinoma in Child–Pugh A patients treated with radical surgery: A retrospective observational study
por: Wu, Binquan, et al.
Publicado: (2019)

The comparison between albumin-bilirubin grade and Child-Pugh grade for assessing the prognosis of hepatocellular carcinoma after thermal ablation: a propensity score-matched analysis
por: Zhang, Jiayi, et al.
Publicado: (2022)

The Significance of Platelet–Albumin–Bilirubin (PALBI) Grade in Hepatocellular Carcinoma Patients Stratified According to Platelet Count
por: Pang, Qing, et al.
Publicado: (2020)

Proton Beam Therapy for Treatment-Naïve Hepatocellular Carcinoma and Prognostic Significance of Albumin-Bilirubin (ALBI) Grade
por: Kim, Tae Hyun, et al.
Publicado: (2022)

Predictive Power of the Albumin–Bilirubin Score for Hepatotoxicity in Stereotactic Ablative Radiation Therapy for Hepatocellular Carcinoma
por: Joo, Jihyeon, et al.
Publicado: (2023)

Comparison of albumin-bilirubin grade versus Child-Pugh score in predicting the outcome of transarterial chemoembolization for hepatocellular carcinoma using time-dependent ROC
por: Zhao, Shoujie, et al.
Publicado: (2020)

Comment on ‘Transarterial chemo-embolisation of hepatocellular carcinoma: impact of liver function and vascular invasion’
por: Huo, Teh-Ia, et al.
Publicado: (2017)

The Association of Albumin-Bilirubin (ALBI) Grade with Mortality Risk in Trauma Patients with Liver Injuries
por: Chou, Sheng-En, et al.
Publicado: (2023)

To determine the prognostic value of the albumin–bilirubin grade (ALBI) in patients underwent transarterial chemoembolization for unresectable hepatocellular carcinoma
por: Khalid, Muhammad Ali, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_a5j4dhm362fn7ise1paq0366jf